ReShape Lifesciences Past Earnings Performance
Past criteria checks 0/6
ReShape Lifesciences's earnings have been declining at an average annual rate of -10.2%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 35.4% per year.
Key information
-10.2%
Earnings growth rate
89.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 35.4% |
| Return on equity | -310.7% |
| Net Margin | -577.2% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ReShape Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 11 | -65 | 32 | 2 |
| 30 Jun 22 | 12 | -71 | 41 | 3 |
| 31 Mar 22 | 13 | -65 | 36 | 3 |
| 31 Dec 21 | 14 | -62 | 31 | 3 |
| 30 Sep 21 | 14 | -35 | 27 | 3 |
| 30 Jun 21 | 14 | -22 | 15 | 2 |
| 31 Mar 21 | 12 | -22 | 15 | 3 |
| 31 Dec 20 | 11 | -22 | 15 | 3 |
| 30 Sep 20 | 12 | -38 | 16 | 3 |
| 30 Jun 20 | 12 | -62 | 18 | 3 |
| 31 Mar 20 | 15 | -74 | 21 | 3 |
| 31 Dec 19 | 15 | -74 | 22 | 3 |
| 30 Sep 19 | 11 | -52 | 22 | 3 |
| 30 Jun 19 | 8 | -28 | 21 | 3 |
| 31 Mar 19 | 4 | -35 | 18 | 4 |
| 31 Dec 18 | 1 | -38 | 19 | 6 |
| 30 Sep 18 | 0 | -42 | 22 | 7 |
| 30 Jun 18 | 1 | -47 | 22 | 8 |
| 31 Mar 18 | 1 | -30 | 23 | 7 |
| 31 Dec 17 | 1 | -30 | 23 | 5 |
| 30 Sep 17 | 1 | -29 | 19 | 5 |
| 30 Jun 17 | 1 | -25 | 18 | 5 |
| 31 Mar 17 | 1 | -23 | 18 | 5 |
| 31 Dec 16 | 1 | -23 | 18 | 5 |
| 30 Sep 16 | 1 | -26 | 21 | 6 |
| 30 Jun 16 | 1 | -23 | 22 | 6 |
| 31 Mar 16 | 0 | -26 | 21 | 7 |
Quality Earnings: 24O is currently unprofitable.
Growing Profit Margin: 24O is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 24O is unprofitable, and losses have increased over the past 5 years at a rate of 10.2% per year.
Accelerating Growth: Unable to compare 24O's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 24O is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: 24O has a negative Return on Equity (-310.65%), as it is currently unprofitable.